Lasik and Vision Surgery Consultation Selling — 60-Min Training

Direct Answer

The LASIK Consult Conversion Reset is a 60-minute training for ophthalmology and refractive-surgery patient counselors at LASIK / SMILE / ICL centers (treatment fees $4,000-$7,000 both eyes) who own the bridge between the surgeon's candidacy verdict and the surgery deposit.

The discipline is brutal and trust-first: screen candidacy before you sell, frame realistic outcomes against the FDA LASIK Quality of Life Project data, name the platform (Alcon Wavelight EX500, Carl Zeiss VisuMax SMILE, Contoura Vision, iLasik) and the surgeon by credential, and only then walk financing math via CareCredit, Cherry, Lending Club Patient Solutions, or in-house plans — with FSA/HSA timing mapped to the calendar.

Built on guidance from the American Society of Cataract & Refractive Surgery (ASCRS), the American Academy of Ophthalmology (AAO), and American Refractive Surgery Council candidacy standards, this session installs a counseling ritual that earns the case, not just closes it.

Section 1 — Why Refractive Counseling Breaks (5 min)

Open with the uncomfortable truth. Most refractive consults lose the patient not at price, but at trust around candidacy and outcomes. Ophthalmology Management's 2026 piece on conversion rates is blunt: the counselors who post the highest convert-and-keep numbers are the ones who say "you're not a candidate" out loud — and mean it — when topography, dry-eye, or corneal thickness disqualifies a patient.

Set the frame on the whiteboard:

• The old refractive consult: Counselor pushes the surgery, glosses over halos, opens with the financing brochure, promises 20/20, books the deposit.
• The new refractive consult: Counselor confirms the surgeon's candidacy verdict first, quotes the FDA Quality of Life Project numbers verbatim, names the laser platform and surgeon's case volume, then opens financing.
• North-star metric: Consult-to-surgery conversion of 55-70% among qualified candidates (per the ASCRS practice-management track), not gross conversion of every walk-in.

Read aloud the AAO patient-counseling principle: *"Informed consent is the consultation, not a form at the end of it."* The room must internalize that disqualifying a patient is a marketing asset — those patients refer friends and come back for PRK, ICL, or refractive lens exchange when they age into it.

End the segment by writing on the board: "We sell the right surgery to the right eye, or we sell nothing today."

Section 2 — The Candidacy-First Consult Brief (15 min)

The brief is the document the counselor builds during the technician workup and surgeon exam — before any price is named. Have every counselor in the room fill this out for the next consult on their schedule, right now.

Verbatim Candidacy-First Consult Brief (counselor fills out, reviews with surgeon):

1. Patient: [Name] — [Age] — [Rx OD/OS] — [Years in current correction]
2. Primary motivator: Sports / career / contact-lens intolerance / cosmetic / dry-eye-from-contacts / other
3. Candidacy verdict from surgeon: Cleared for LASIK / SMILE / PRK / ICL / RLE / Not a candidate today — with reason
4. Red-flag screen: Pachymetry under 480 microns, Pentacam topography irregularity, dry-eye OSDI score above 22, pupil over 7 mm scotopic, autoimmune (lupus / RA), pregnancy or nursing, age under 18, unstable Rx in last 12 months
5. The ONE concern the patient said out loud: [e.g., "I'm a firefighter and I read about halos at night"]
6. Platform the surgeon recommends and WHY: [e.g., Alcon Wavelight EX500 with Contoura topography-guided for irregular astigmatism]
7. My job on this consult: Confirm candidacy, walk realistic outcomes against FDA Quality of Life Project, name the surgeon's case volume and platform, then financing. No price before trust.

Coach the room on the one-concern rule — from ASCRS counseling tracks: every refractive patient walks in with one private fear (night halos, going blind, "what if it fails," the surgeon "just wants my money"). Your job is to surface it in the first eight minutes and name it back to them. If you don't, financing won't close the gap.

Show the bad example: *"You're a great candidate — let's talk about how to pay for it."* That's not counseling, that's a car-lot pitch with a microkeratome.

Section 3 — The Realistic-Outcome Conversation (10 min)

This is where most counselors over-promise and lose the patient three weeks post-op. Drill the exact language.

Use the FDA LASIK Quality of Life Project (LQOLP) and PROWL-1 / PROWL-2 findings as your anchor — they're the only peer-reviewed, federally-run outcome data, published with ASCRS and AAO collaboration. The headline numbers every counselor must memorize:

• 96-99% of patients achieve 20/40 or better uncorrected (driving vision), per PROWL-1.
• ~90% achieve 20/20 or better, per the 2020 Institute aggregate.
• Dry eye symptoms are reported by ~28% of patients at 3 months, dropping to ~5% at 12 months.
• Visual symptoms (halos, glare, starbursts) are reported by ~40% at 3 months, ~20% persisting at 6 months.

Teach the counselors to say the dry-eye and halo numbers out loud, unprompted. American Refractive Surgery Council counseling guidance is explicit: patients who hear the risks from you trust you. Patients who Google them after the deposit, refund.

What to NEVER say in front of a refractive patient (read these aloud, slowly):

• "You'll have perfect vision." (Not a clinical claim — FDA-actionable language. Use "most patients achieve 20/20 or better uncorrected.")
• "There are no real side effects." (Lie. Dry eye and night vision symptoms are documented in PROWL.)
• "This is the same as every other LASIK." (Erases your platform advantage — Wavelight, VisuMax, Contoura are differentiators.)
• "Don't worry about the price, financing will handle it." (Dismisses the concern; opens objection later.)
• "Our surgeon has done thousands." (Vague. Use the real number: "Dr. Patel has performed over 18,000 refractive procedures since 2009.")
• "Everyone is a candidate these days." (False, and ASCRS patient-safety bulletins call it out as the #1 misinformation driver.)

The AAO Code of Ethics is clear: refractive counseling is informed consent in real time. Talk like a clinician, not a closer.

Section 4 — The Technology and Surgeon Credibility Close (10 min)

The patient already Googled LASIK. They've seen the cheap ads and the horror stories. Your job is to make this surgeon, this platform, this room feel like the safest choice in a 90-mile radius. Run the verbatim script.

Verbatim Technology and Surgeon Script (counselor delivers, surgeon optional):

Counselor: "Before we talk about anything else, let me tell you exactly what's going to happen and who is doing it. Dr. Patel is fellowship-trained in cornea and refractive surgery at the Bascom Palmer Eye Institute, and she's performed over 18,000 refractive procedures since 2009.

She's an ASCRS member and a clinical investigator on two FDA submissions."

[Pause. Let it land. Do not fill silence.]

Counselor: "For your eyes specifically, she's recommending the Alcon Wavelight EX500 excimer laser with Contoura Vision topography-guided treatment. That platform tracks your unique corneal map at 1,050 Hz, which means it adjusts in real time. The flap is made with the iLasik femtosecond laser — no blade.

Treatment time per eye is roughly 8 seconds of laser."

[Show the platform brochure or screen. Point to the laser if visible from the consult room.]

Counselor: "You mentioned night halos as your concern. Contoura is specifically the platform that produced the best low-light outcomes in the FDA topography-guided trial — patients in that study reported better night vision after surgery than they had with glasses. That's why she picked it for you."

[Now name the alternative explicitly — it builds trust.]

Counselor: "If for any reason at the pre-op you don't feel ready, we have SMILE on the Carl Zeiss VisuMax as an alternative — smaller incision, slightly different recovery profile. Dr. Patel will walk you through both if you'd like."

Do NOT:

• Trash competitors by name. ("Those discount LASIK places use older lasers...") AAO ethics flags it; patients hear it as defensive.
• Quote a surgeon's case volume you can't verify in the office tomorrow.
• Bundle platforms ("we have all the lasers"). Name the one that fits this eye, and why.
• Skip the surgeon's fellowship and board status — these are the single highest credibility signals per American Refractive Surgery Council counseling research.
• Promise the surgeon will personally do every step — be honest about the role of the certified ophthalmic technician in workup and the surgeon in the actual laser.

Section 5 — Financing, FSA/HSA Timing, and the Money Conversation (15 min)

Now — and only now — open the financing folder. Build the operating math on the board.

The math (real numbers — write these on the whiteboard):

• All-in both-eyes treatment: $4,400 entry tier (basic LASIK), $5,200 mid (iLasik with Contoura), $6,800 premium (Custom Wavelight + lifetime enhancement plan), $7,000+ for SMILE on VisuMax at most premium practices.
• CareCredit 24-month no-interest on a $5,200 case = $216.67/month. (Patient must clear balance in promo window; retroactive interest if they don't — say that out loud.)
• Cherry approves to $10,000 with a soft credit pull, fixed APR, 3-24 month terms. Useful for thin-credit patients CareCredit declines.
• Lending Club Patient Solutions: Larger loan sizes, fixed terms 24-84 months, predictable monthly — no 0% promo.
• In-house financing: 12 months, often 0% interest, deposit $500-$1,000, 5-8% delinquency is the practice's risk to absorb.
• FSA timing: Annual limit $3,300 (2025) / $3,400+ (2026) per the IRS. If today is November, advise the patient to split surgery across calendar years — pre-op imaging this year, surgery in January — to double-dip two FSA cycles for ~$6,700 tax-advantaged.
• HSA: No annual contribution-use timing — funds carry forward. But HSA is a triple tax-advantaged account, so flag the savings: at a 24% marginal rate on $5,200, that's ~$1,248 in effective discount vs. Paying with after-tax dollars.

Quote it as "$216 a month — about $7 a day, less than your contact-lens subscription and a coffee." CareCredit provider data shows the coffee-a-day frame moves patients off price objection more reliably than any discount.

Common refractive financing objections (rehearse the comebacks):

• *"It's a lot of money."* — "It is. Most patients spend $650 a year on contacts, solution, and exams. Over 15 years that's $9,750 — more than the surgery, and you still need readers in your 40s. The math flips around year 7."
• *"What if I'm not happy with the result?"* — "Dr. Patel includes a lifetime enhancement plan in the premium tier — if your vision regresses in the next 10 years and you still qualify, the enhancement is covered. That's why we quote the premium tier first."
• *"I want to think about it / talk to my spouse."* — "Of course. Here's what we'll do: I'll hold the surgeon's next available slot for seven days, no deposit. If you decide it's right, the slot is yours. If not, we let it go and re-screen in a year. Sound fair?"
• *"My friend had LASIK 10 years ago and now needs readers."* — "Presbyopia is unavoidable — it's the lens, not the cornea LASIK reshaped. We always disclose that. For patients in their 40s, Dr. Patel discusses monovision LASIK or refractive lens exchange as alternatives."
• *"I saw an ad for $250 per eye somewhere."* — "I've seen those too. Ask them which laser platform, which surgeon by name, how many procedures that surgeon has performed, and whether Contoura or topography-guided treatment is included. Then come back and compare."

Section 6 — Commitments and Close (5 min)

Each counselor leaves with four written commitments, taped above their workstation:

• Every consult starts with the candidacy verdict — said out loud, in plain English, before any price.
• I will quote the FDA Quality of Life Project numbers (dry eye ~28% at 3 months, visual symptoms ~40% at 3 months) unprompted on every consult.
• I will name the surgeon by fellowship and case volume, and name the laser platform (Wavelight EX500, VisuMax SMILE, iLasik with Contoura) for every patient.
• Financing opens only after trust is built — and I'll quote it as coffee-a-day, walk FSA/HSA timing to the calendar, and offer a 7-day held slot when the patient wants to think.

Close by reading the ASCRS practice-management principle aloud: *"The refractive surgery counselor's job is to make sure the right patient gets the right procedure at the right time — conversion follows trust, never the other way around."*

Then pin the candidacy-first brief template in the team Slack and on every workup-room clipboard.

FAQ

Q1: What do I say when the surgeon disqualifies someone who really wants the surgery? A: Tell them the truth, name the path. "Your corneas are 460 microns and our threshold is 480 — LASIK isn't safe for you today, but ICL (Implantable Collamer Lens) doesn't touch the cornea, and **Dr.

Patel does ICL cases on the Carl Zeiss VisuMax platform. Want to walk through that option?" ASCRS** patient-safety bulletins say honest disqualification is your #1 referral driver.

Q2: Patient asks "what's your conversion rate" — what do I say? A: Don't quote a number — pivot. "We aim for the right fit, not the highest conversion. About 65-70% of patients we screen qualify and proceed; the rest we either send to a more appropriate procedure like PRK or ICL, or ask them to come back when their prescription has been stable for a year." This is the framing ASCRS counseling tracks and Ophthalmology Management recommend.

Q3: How do I handle the patient who already had a "free" consult elsewhere and was told they're a candidate? A: Respect it, then re-screen. "Glad you got that opinion. Different practices use different thresholds — **Dr.

Patel uses Pentacam Scheimpflug imaging and OSDI dry-eye scoring** as part of her workup. Let's run our full diagnostic and compare." If your screen disqualifies them, your protocol is what saved them.

Q4: When should I bring up SMILE vs. LASIK vs. PRK vs. ICL? A: After the surgeon's recommendation, not before. The patient should hear one primary recommendation plus a brief note on the alternative if they hesitate. The AAO patient-education guidance is to avoid menu-style consults — they create decision paralysis and lower conversion.

Q5: What's the right way to use FSA and HSA in November or December? A: Two moves. (1) If they have unused FSA funds expiring December 31, push the pre-op exam and any deposit into December to use this year's allowance, then schedule surgery in January for next year's allowance — effectively doubling the tax-advantaged spend to roughly $6,700.

(2) For HSA holders, walk the 24% bracket savings math — at a $5,200 case, that's ~$1,248 in real-dollar discount vs. After-tax payment.

Q6: A patient says "my eye doctor told me LASIK is dangerous." How do I respond? A: Don't argue with their doctor. "Your optometrist's job is to be conservative — that's how they protect you. Refractive surgery has been FDA-approved since 1995, ASCRS publishes annual safety data, and the FDA LASIK Quality of Life Project is the largest patient-reported outcomes study on any elective surgery.

I'd encourage you to read the PROWL-1 and PROWL-2 studies and bring questions back. We'll wait." Patients almost always come back.

Sources

1. American Society of Cataract and Refractive Surgery (ASCRS), *Annual Meeting Practice Management Sessions and Patient Safety Bulletins*, ascrs.org, 2024-2026.
2. American Academy of Ophthalmology (AAO), *Code of Ethics and Patient Counseling Standards for Refractive Surgery*, aao.org, 2025.
3. U.S. Food & Drug Administration, *LASIK Quality of Life Collaboration Project (LQOLP) — PROWL-1 and PROWL-2 Studies*, fda.gov, published 2014, ongoing safety guidance through 2025.
4. American Refractive Surgery Council (ARSC), *General LASIK Candidate Guidelines and Patient Counseling Best Practices*, americanrefractivesurgerycouncil.org, 2025.
5. Ophthalmology Management, *A Practical Approach to High Conversion Rates*, January 2026 issue, ophthalmologymanagement.com.
6. Association for Research in Vision and Ophthalmology (ARVO), *Annual Meeting Refractive Surgery Outcomes Track*, arvo.org, 2025.
7. Alcon, *Wavelight EX500 Excimer Laser and Contoura Vision Topography-Guided Treatment — Surgeon and Counselor Reference*, alcon.com, 2025; Carl Zeiss Meditec, *VisuMax SMILE Platform Clinical Outcomes Reference*, zeiss.com, 2025.
8. CareCredit and Synchrony Financial, *Ophthalmology Patient Financing Provider Insights*, carecredit.com/providers, 2025; Cherry and Lending Club Patient Solutions provider materials, 2025.